Royal Bank of Canada
GBT

Royal Bank of Canada’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Royal Bank of Canada’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-400
Closed -$21K – 7327
2019
Q1 		$21K Buy
400
+300
+300% +$14.7K ﹤0.01% 5639
2018
Q4 		$4K Buy
+100
New +$3.75K ﹤0.01% 6276

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Royal Bank of Canada's GBT Position: Q4 2022 in Review

Royal Bank of Canada sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 201,624 shares — an estimated $13.7M sold.

Royal Bank of Canada first reported a position in GBT in Q3 2015 and held it in 28 quarters. The position peaked at $13.7M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Royal Bank of Canada reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 201,624 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $13.7M.
  • Royal Bank of Canada first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 28 quarters.
  • Royal Bank of Canada's Global Blood Therapeutics, Inc. position peaked at $13.7M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Royal Bank of Canada's 13F filing for Q4 2022, filed 14 Feb 2023.